Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
- German Cancer Research Center in the Helmholtz Association (DKFZ)
- Adelaide University
- Deutsches Krebsforschungszentrum
- Technical University of Munich
- Autonomous University of Madrid (Universidad Autónoma de Madrid)
- IBIMA Plataforma BIONAND
- Karl Landsteiner University of Health Sciences
- Leibniz-Institut für Analytische Wissenschaften – ISAS – e.V.
- Lunds universitet
- Medical University of Gdańsk
- Medical University of Silesia
- Prinses Máxima Centrum
- Radboud University Medical Center (Radboudumc)
- St. Anna Kinderkrebsforschung e.V.
- The University of Chicago
- University of Amsterdam (UvA)
- University of Crete
- University of Oldenburg
- University of Pittsburgh
- University of Tübingen •
- Vrije Universiteit Amsterdam (VU)
- 11 more »
- « less
-
Field
-
, as well as interactions between tumors and the immune system. Translational Cancer Research – Bridging basic and clinical research through molecular oncology and hematology, medical physics with a
-
-based AI for multidisciplinary tumor boards. The successful candidate will develop LLM-based pipelines, semantic harmonization, and transformer-based temporal models on a large multimodal oncology dataset
-
accompanied by relevant evidence, uncertainty estimates, and transparent explanations aligned with current clinical guidelines? Preferred starting date: 1 November 2026 Where to apply Website https
-
) that connects different countries with the overarching aim to develop cutting-edge human in vitro and in silico biomedical tools to better understand the biology of brain disease/disorders (see: https://visi
-
team combining molecular biology, immunology, and clinical hemato-oncology expertise. The candidate will take an active role across the full experimental cycle of the: data generation, analysis, and
-
German Cancer Research Center in the Helmholtz Association (DKFZ) | Oettingen in Bayern, Bayern | Germany | about 2 months ago
research, thereby developing new strategies for personalized oncology in prevention, diagnosis, and treatment of cancer. DKTK conducts transformative translational cancer research, educates the next
-
methods and theory for analysing time-to-event data when a fraction of the population is immune to the event of interest (‘cured’). For example, in oncology the event of interest is cancer relapse/death
-
About us Join a cutting-edge cross-border research initiative in translational pancreatic oncology, bridging two leading university medical centers: the University Medical Center Groningen (UMCG) and the
-
German Cancer Research Center in the Helmholtz Association (DKFZ) | Oettingen in Bayern, Bayern | Germany | 3 months ago
research, thereby developing new strategies for personalized oncology in prevention, diagnosis, and treatment of cancer. DKTK conducts transformative translational cancer research, educates the next
-
Faculty.Professor.Research Assistant - Full-Time Med-Medicine - Pennsylvania-Pittsburgh - (26001685) The Department of Medicine- The Division of Malignant Hematology/Medical Oncology